©The Author(s) 1998.
World J Gastroenterol. Oct 15, 1998; 4(Suppl2): 22-23
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.iSuppl2.22
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.iSuppl2.22
Table 1 Physician global assessment of disease activity n (%)
| UC | CD | Total | |
| Symptom free | 176 (45) | 62 (31) | 238 (40) |
| Improvement | 151 (38) | 94 (47) | 245 (41) |
| No change | 22 (6) | 16 (8) | 38 (6) |
| Worse | 9 (2) | 10 (5) | 19 (3) |
| Unknown | 36 (9) | 19(9) | 55 (9) |
Table 2 Treatment
| UC (%) | CD (%) | |
| 5-ASA or SASP | 65 | 67 |
| Corticosteroids | 13 | 26 |
| Immunosuppressives | 3 | 11 |
| None | 33 | 19 |
- Citation: Shivananda S. Epidemiology and disease outcome in inflammatory bowel disease: observations from the European Collaborative Study. World J Gastroenterol 1998; 4(Suppl2): 22-23
- URL: https://www.wjgnet.com/1007-9327/full/v4/iSuppl2/22.htm
- DOI: https://dx.doi.org/10.3748/wjg.v4.iSuppl2.22
